Clinical Trial Update: Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating chemotherapy after surgical resection for high-risk pancreatic neuroendocrine tumors, with recruitment ongoing and inclus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• Chemotherapy (chemotherapy)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Metastatic Malignant Neoplasm in the Liver, Pancreatic Neuroendocrine Tumor | Phase 2 | Status: RECRUITING